Medicure Inc. (CVE:MPH) Stock Catapults 28% Though Its Price And Business Still Lag The Industry
Medicure Inc. (CVE:MPH) shareholders would be excited to see that the share price has had a great month, posting a 28% gain and recovering from prior weakness. Not all shareholders will be feeling jubilant, since the share price is still down a very disappointing 21% in the last twelve months.
Even after such a large jump in price, Medicure may still be sending very bullish signals at the moment with its price-to-sales (or “P/S”) ratio of 0.4x, since almost half of all companies in the Biotechs industry in Canada have P/S ratios greater than 8.1x and even P/S higher than 48x are not unusual. However, the P/S might be quite low for a reason and it requires further investigation to determine if it’s justified.
